Skip to content

ALXO - ALX ONCOLOGY HOLDINGS INC - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchA

Alx Oncology Holdings

ALXO · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

A

ALXOAlx Oncology Holdings

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 21

52-wk high: $2.66
52-wk low: $0.96
Prev close: $1.85
Mkt cap: $284.9M
Beta: 0.40
P/S: 5086.0x

Smart money

8 funds hold a position and insiders have been net selling.

Real smart money

Funds holding this stock

8 holders

Combined position$36.2M

MW
Marshall Wace
Q2 2026 13F
$6.4M
position
TS
Two Sigma
Q2 2026 13F

Earnings

Earnings

Results versus expectations

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $285M

Valuation

P/S5085.96
P/B2.11

Quality

Operating margin0.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: ALXO
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $284.85M
Beta: 0.40

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/B

2.1x

Profit margin

+0.0%

Op margin

+0.0%

ROE

-80.6%

$4.5M

position

MI

Millennium

Israel Englander · Q2 2026 13F

$3.2M

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for ALXO

No recent Congress trade
No recent market-voice mention

No earnings history on record for this stock yet.

The next reported quarter will appear here

Next report

What the street expects next

EPS expected

-$0.16

-$0.16 to -$0.16

Revenue expected

$0.00

5 analysts

-80.6%

ROA-40.4%

Growth

Beta0.40